ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
electroCore, Inc. (ECOR) stock surged +6.95%, trading at $6.62 on NASDAQ, up from the previous close of $6.19. The stock opened at $6.11, fluctuating between $6.11 and $6.74 in the recent session.
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Employees | 73 |
Beta | 0.25 |
Sales or Revenue | $16.03M |
5Y Sales Change% | 4.71% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |